Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents

References

• National Cancer Institute Available from: http://www.cancer.gov/Accessed October 28, 2015
   Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)The Global Burden of Disease: 2004 UpdateGenevaWHO Available from: http://www.who.int/topics/global_burden_of_disease/en/Accessed October 28, 2015
   Google Scholar
• AzizNMRowlandJHTrends and advances in cancer survivorship research: challenge and opportunitySemin Radiat Oncol200313324826612903014
   PubMed Web of Science ®Google Scholar
• PetrelliNJWinerEBrahmerJClinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening – a report from the American Society of Clinical OncologyJ Clin Oncol200927356052606919901123
   PubMed Web of Science ®Google Scholar
• DavidsonSDMilanesaDMMallouhCChoudhuryMSTazakiHKonnoSA possible regulatory role of glyoxalase I in cell viability of human prostate cancerUrol Res200230211612112086016
   PubMedGoogle Scholar
• RabbaniNThornalleyPJGlyoxalase in diabetes, obesity and related disordersSemin Cell Dev Biol201122330931721335095
   PubMed Web of Science ®Google Scholar
• ThornalleyPJRabbaniNGlyoxalase in tumourigenesis and multidrug resistanceSemin Cell Dev Biol201122331832521315826
   PubMed Web of Science ®Google Scholar
• XueMRabbaniNThornalleyPJGlyoxalase in ageingSemin Cell Dev Biol201122329330121320620
   PubMed Web of Science ®Google Scholar
• SakamotoHMashimaTKizakiAGlyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosisBlood200095103214321810807791
   PubMed Web of Science ®Google Scholar
• National Toxicology ProgramFinal report on carcinogens background document for formaldehydeRep Carcinog Backg Doc201010-5981i-512
   PubMedGoogle Scholar
• ChaplenFWIncidence and potential implications of the toxic metabolite methylglyoxal in cell culture: a reviewCytotechnology199826317318322358615
   PubMed Web of Science ®Google Scholar
• SuttisansaneeUHonekJFBacterial glyoxalase enzymesSemin Cell Dev Biol201122328529221310258
   PubMed Web of Science ®Google Scholar
• RulliACarliLRomaniRExpression of glyoxalase I and II in normal and breast cancer tissuesBreast Cancer Res Treat2001661677211368412
   PubMed Web of Science ®Google Scholar
• MeariniERomaniRMeariniLDiffering expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomasEur J Cancer200238141946195012204678
   PubMed Web of Science ®Google Scholar
• FeierbergILuzhkovVÅqvistJComputer simulation of primary kinetic isotope effects in the proposed rate-limiting step of the glyoxalase I catalyzed reactionJ Biol Chem200027530226572266210801792
   PubMed Web of Science ®Google Scholar
• ThornalleyPProtecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapyBiochem Soc Trans20033161372137714641066
   PubMedGoogle Scholar
• ThornalleyPGlyoxalase I-structure, function and a critical role in the enzymatic defence against glycationBiochem Soc Trans20033161343134814641060
   PubMedGoogle Scholar
• ClellandJAllenRThornalleyPInhibition of growth of human leukaemia 60 cells by S-2-hydroxyacylglutathiones and monoethyl ester derivativesBiochem Pharmacol19924410195319591449514
   PubMed Web of Science ®Google Scholar
• EdwardsLAdesidaAThornalleyPInhibition of human leukaemia 60 cell growth by S-d-lactoylglutathione in vitro. Mediation by metabolism to N-d-lactoylcysteine and induction of apoptosisLeuk Res199620117268632674
   PubMed Web of Science ®Google Scholar
• EdwardsLThornalleyPPrevention of S-d-lactoylglutathione-induced inhibition of human leukaemia 60 cell growth by uridineLeuk Res19941897177227934147
   PubMed Web of Science ®Google Scholar
• ThornalleyPTisdaleMInhibition of proliferation of human promyelocytic leukaemia HL60 cells by S-D-lactoylglutathione in vitroLeuk Res19881211–128979042905755
   PubMed Web of Science ®Google Scholar
• FeierbergI2003Computational Studies of Enzymatic Enolization Reactions and Inhibitor Binding to a Malarial ProteaseDepartment of Cell and Molecular BiologyUppsalaActa Universitatis UpsaliensisDoctor of Philosophy54
   Google Scholar
• CameronADOlinBRidderströmMMannervikBJonesTACrystal structure of human glyoxalase I – evidence for gene duplication and 3D domain swappingEMBO J19971612338633959218781
   PubMed Web of Science ®Google Scholar
• CameronADRidderströmMOlinBKavaranaMJCreightonDJMannervikBReaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogueBiochemistry19993841134801349010521255
   PubMed Web of Science ®Google Scholar
• MoreSSVinceRA metabolically stable tight-binding transition-state inhibitor of glyoxalase-IBioorg Med Chem Lett200616236039604216997560
   PubMed Web of Science ®Google Scholar
• VinceRDalugeSWaddWBInhibition of glyoxalase I by S-substituted glutathionesJ Med Chem19711454024045117686
   PubMed Web of Science ®Google Scholar
• Al-BalasQHassanMAl-OudatBAlzoubiHMhaidatNAlmaaytahAGeneration of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitorsMolecules20121712137401375823174893
   PubMed Web of Science ®Google Scholar
• MoreSSVinceRDesign, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-IBioorg Med Chem Lett200717133793379717513107
   PubMed Web of Science ®Google Scholar
• MoreSSVinceRInhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitorsJ Med Chem200952154650465619610604
   PubMed Web of Science ®Google Scholar
• SuzukiTMiyataNRational design of non-hydroxamate histone deacetylase inhibitorsMini Rev Med Chem20066551552616719825
   PubMed Web of Science ®Google Scholar
• MaingotLLerouxFLandryVNew non-hydroxamic ADAMTS-5 inhibitors based on the 1, 2, 4-triazole-3-thiol scaffoldBioorg Med Chem Lett201020216213621620846863
   PubMed Web of Science ®Google Scholar
• TakasawaRSaekiKTaoADelphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase IBioorg Med Chem201018197029703320801663
   PubMed Web of Science ®Google Scholar
• TakasawaRTakahashiSSaekiKSunagaSYoshimoriATanumaS-IStructure–activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effectsBioorg Med Chem20081673969397518258440
   PubMed Web of Science ®Google Scholar
• TakasawaRTaoASaekiKDiscovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophoreBioorg Med Chem2011211443374342
   Web of Science ®Google Scholar
• KoskaJRSpassovVZMaynardAJFully automated molecular mechanics based induced fit protein–ligand docking methodJ Chem Inf Model200848101965197318816046
   PubMed Web of Science ®Google Scholar
• MadsenASKristensenHMLanzGOlsenCAThe effect of various zinc binding groups on inhibition of histone deacetylases 1–11ChemMedChem20149361462624375963
   PubMed Web of Science ®Google Scholar
• KawaiKNagataNMetal–ligand interactions: an analysis of zinc binding groups using the Protein Data BankEur J Med Chem20125127127622405284
   PubMed Web of Science ®Google Scholar